Cargando…
Efficacy and safety of dual filtration plasmapheresis combined with biological agents in active refractory rheumatod arthritis: A retrospective cohort study
To investigate the effectiveness of dual filtration plasmapheresis (DFPP), a novel blood purification treatment, as a rapid and sustained disease-modifying therapy for active refractory rheumatoid arthritis (RA). A retrospective cohort study had been conducted. One hundred fifty three patients aged...
Autores principales: | Xing, Yida, Wang, Shouquan, Liu, Changyan, Wang, Hongjiang, Zhao, Mingli, Jin, Bo, Kong, Xiaodan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360202/ https://www.ncbi.nlm.nih.gov/pubmed/32664100 http://dx.doi.org/10.1097/MD.0000000000020966 |
Ejemplares similares
-
Therapeutic efficacy of combined glucocorticoid, intravenous cyclophosphamide, and double-filtration plasmapheresis for skin sclerosis in diffuse systemic sclerosis
por: Suga, Kensuke, et al.
Publicado: (2020) -
Successful treatment of thrombotic thrombocytopenic purpura with plasmapheresis and anti-CD20 antibodies in a patient with immune thrombocytopenia and systemic lupus erythematosus: Case report
por: Jung, Ju-Yang, et al.
Publicado: (2022) -
Comparison of glucocorticoids and painkiller prescribed days between rheumatoid arthritis patients receiving early and late treatment with a biological agent via a population-based cohort study
por: Lee, Zon-Min, et al.
Publicado: (2022) -
Extended-release tofacitinib for refractory Behçet disease: A case report
por: Wang, Chrong-Reen, et al.
Publicado: (2022) -
Comparative efficacy and safety of JAK inhibitors and leflunomide in rheumatoid arthritis: A protocol for systematic review and meta-analysis
por: Zhang, Xiaogang, et al.
Publicado: (2022)